
NAME: Targeted Genetics Corp.
CID: 0000921114

Mar 1, 2005

$100 to $500 MC

Biotech: Gene therapy.  Trials for AIDs and cystic fibrosis.  $100M
market cap gambling for a cure.

Jan 12, 2006

MC down to 44M.  Still losing money.

Apr 8, 2012

Crash and refored into Ampliphi Biosciences.  Will stop tracking this.  Company lost $320M of investor money over it's lifetime.
